May 9, 2022 01:01 PM EDTUpdated May 10, 08:44 AM
Pharma
Law

Il­lu­mi­na forced to pay al­most $334M as it los­es DNA se­quenc­ing patent case

Tyler Patchen

News Reporter

A fed­er­al ju­ry in Delaware on Fri­day or­dered Il­lu­mi­na to pay Com­plete Ge­nomics Inc., a sub­sidiary of the BGI Group, the world’s largest mak­er of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times